首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Regional myocardial ajmaline concentration and antiarrhythmic activity for ischaemia- and reperfusion-induced arrhythmias in rats.
【2h】

Regional myocardial ajmaline concentration and antiarrhythmic activity for ischaemia- and reperfusion-induced arrhythmias in rats.

机译:大鼠局部缺血性再灌注所致心律失常的局部心肌艾玛琳浓度和抗心律失常活性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. Antiarrhythmic actions of ajmaline against ischaemia (left coronary artery occlusion for 15 min) and subsequent reperfusion-induced arrhythmias were investigated in anaesthetized rats. 2. Ajmaline (2 mg kg-1, i.v.) was effective in suppressing ischaemia-induced arrhythmias whether given pre- or post-occlusion. 3. Ajmaline diminished the reperfusion-induced arrhythmias completely when given pre-occlusion but had little effect when given post-occlusion. 4. Reperfusion-induced increases in plasma enzyme activities of lactate dehydrogenase, glutamate-oxaloacetate transaminase and creatine phosphokinase were prevented more effectively when ajmaline was given pre-occlusion rather than post-occlusion. 5. Fifteen min post-occlusion, the ajmaline concentrations in the ischaemic ventricle were 18.42 +/- 1.66 and 1.18 +/- 0.15 micrograms g-1 for pre- and post-occlusion administration, respectively. However, ajmaline concentrations in whole blood and normal ventricle were not significantly different between pre- and post-occlusion administration. 6. We suggest that the beneficial effect of ajmaline against reperfusion-induced arrhythmias is related to the ischaemic myocardial concentration of ajmaline which is markedly affected by the time of drug administration (i.e. pre- and post-occlusion).
机译:1.在麻醉的大鼠中,研究了阿玛茶碱对缺血的抗心律失常作用(左冠状动脉闭塞15分钟)以及随后的再灌注引起的心律不齐。 2.不论在闭塞之前还是闭塞后,都可以使用艾玛琳(2 mg kg-1,i.v.)有效抑制缺血引起的心律不齐。 3.闭塞前,艾玛琳可完全减轻再灌注引起的心律不齐,但闭塞后效果不明显。 4.当在闭塞前(而不是闭塞后)给予阿玛琳时,可以更有效地防止再灌注诱导的乳酸脱氢酶,谷氨酸-草酰乙酸转氨酶和肌酸磷酸激酶血浆酶活性的增加。 5.闭塞后15分钟,在闭塞前和闭塞后给药,缺血性心室中的艾玛琳浓度分别为18.42 +/- 1.66和1.18 +/- 0.15微克g-1。然而,在阻塞前和阻塞后给药之间,全血和正常心室中的艾玛琳浓度没有显着差异。 6.我们建议,阿玛琳对再灌注引起的心律不齐的有益作用与阿玛琳的缺血性心肌浓度有关,阿玛琳的缺血性心肌浓度受药物给药时间(即闭塞前后)的影响明显。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号